New CEP for Alfuzosin HCl

Last Updated on Dienstag, 18 Dezember 2012 07:23 Written by admin Freitag, 3 April 2009 07:23

By April 1st 2009 the EDQM granted a new Certificate of Suitability for Excella’s API Alfuzosin HCl. This increases the number of actual CEP’s for our products to thirteen. Our Regulatory Affairs & Customer Service Department is happy to send copies of these certificates to our customers for the respective products. Please contact Frank Jellen at +49 9128 404 685 or by e-mail to fjellen@excella-pharma-source.de with your inquiry.